Menu

Blog

Archive for the ‘finance’ category: Page 3

Nov 18, 2021

XPrize announces first winners for Elon Musk’s $100-Million Carbon removal competition

Posted by in categories: Elon Musk, finance

The first prize money has been awarded in the largest XPrize competition ever held, with 23 student teams getting financial injections to further their carbon removal technology.

Among the winners are a variety of forward-thinking initiatives addressing the issue of rising carbon dioxide levels in the atmosphere, as well as those that seek to address more than one environmental issue at the same time.

The US$100 million Carbon Removal XPrize was launched in February with the goal of developing technology that can remove CO2 from the seas and the atmosphere.

Nov 17, 2021

Qualcomm to supply BMW with self-driving car chips

Posted by in categories: business, finance, mobile phones, robotics/AI, transportation

Qualcomm is diversifying from mobile phones, to supplying chips for BMW’s self-driving cars.

#News #Reuters #BMW #Qualcomm #SelfDriving.

Continue reading “Qualcomm to supply BMW with self-driving car chips” »

Nov 13, 2021

Food inflation is the next big threat to Canadians’ finances

Posted by in categories: finance, food

Food inflation could hit 6 per cent in the coming months. After that, it’s anyone’s guess.

Nov 6, 2021

Gwen Darien — EVP, Patient Advocacy and Engagement, National Patient Advocate Foundation

Posted by in categories: biotech/medical, finance, health, policy

EVP, patient advocacy & engagement, national patient advocate foundation.


Gwen Darien is Executive Vice President for Patient Advocacy and Engagement, at the National Patient Advocate Foundation (https://www.npaf.org/), an organization with a mission of bringing patient voices to health system delivery reform, developing and driving initiatives promoting equitable access to affordable quality health care, and prioritizing the patient voice in health system delivery reform to achieve person-centered care. She is also Executive Vice President at their sister organization, Patient Advocate Foundation (https://www.patientadvocate.org/), a national non-profit organization which provides case management services and financial aid to Americans with chronic, life threatening and debilitating illnesses.

Continue reading “Gwen Darien — EVP, Patient Advocacy and Engagement, National Patient Advocate Foundation” »

Nov 5, 2021

Chinese companies report alarming dip in profits as the perfect storm hits the Chinese economy

Posted by in categories: business, economics, finance, food

The Chinese economy has been hit by a perfect storm. In the third quarter of the ongoing financial year, official Chinese data revealed that GDP growth stood at 4.9 percent, down from 7.9 percent in the previous quarter. This decline in GDP growth is directly eating into profits of big Chinese companies.

Rising prices and low consumer spending create a perfect storm in the Chinese economy:

There are two broad factors that are affecting business earnings in China-raw material inflation and low consumer spending.

Continue reading “Chinese companies report alarming dip in profits as the perfect storm hits the Chinese economy” »

Nov 4, 2021

China Is Permanently Damaging Its Marketplace

Posted by in category: finance

Talk of war, stagflation and rationing is eroding the country’s confidence and affecting the dynamics of its financial industry.

Nov 2, 2021

Partnership to Expand Effective Gene Therapies for Rare Diseases

Posted by in categories: biotech/medical, economics, finance, genetics

Rare diseases aren’t so rare. Collectively, up to 30 million Americans, many of them children, are born with one of the approximately 7,000 known rare diseases. Most of these millions of people also share a common genetic feature: their diseases are caused by an alteration in a single gene.

Many of these alterations could theoretically be targeted with therapies designed to correct or replace the faulty gene. But there have been significant obstacles in realizing this dream. The science of gene therapy has been making real progress, but pursuing promising approaches all the way to clinical trials and gaining approval from the U.S. Food and Drug Administration (FDA) is still very difficult. Another challenge is economic: for the rarest of these conditions (which is most of them), the market is so small that most companies have no financial incentive to pursue them.

To overcome these obstacles and provide hope for those with rare diseases, we need a new way of doing things. One way to do things differently—and more efficiently—is the recently launched Bespoke Gene Therapy Consortium (BGTC). It is a bold partnership of NIH, the FDA, 10 pharmaceutical companies, and several non-profit organizations [1]. Its aim: optimize the gene therapy development process and help fill the significant unmet medical needs of people with rare diseases.

Continue reading “Partnership to Expand Effective Gene Therapies for Rare Diseases” »

Nov 2, 2021

NeuReality and IBM team up to develop AI inference platforms

Posted by in categories: finance, robotics/AI, space

The technology aims to deliver cost and power consumption improvements for deep learning use cases of inference, the companies said. This development follows NeuReality’s emergence from stealth earlier in February with an $8 million seed round to accelerate AI workloads at scale.

AI inference is a growing area of focus for enterprises, because it’s the part of AI where neural networks actually are applied in real application and yield results. IBM and NeuReality claim their partnership will allow the deployment of computer vision, recommendation systems, natural language processing, and other AI use cases in critical sectors like finance, insurance, healthcare, manufacturing, and smart cities. They also claim the agreement will accelerate deployments in today’s ever-growing AI use cases, which are already deployed in public and private cloud datacenters.

NeuReality has competition in Cast AI, a technology company offering a platform that “allows developers to deploy, manage, and cost-optimize applications in multiple clouds simultaneously.” Some other competitors include Comet.ml, Upright Project, OctoML, Deci, and DeepCube. However, this partnership with IBM will see NeuReality become the first start-up semiconductor product member of the IBM Research AI Hardware Center and a licensee of the Center’s low-precision high performance Digital AI Cores.

Continue reading “NeuReality and IBM team up to develop AI inference platforms” »

Nov 1, 2021

China: Corporate debt crisis spreads/Zhongwang: suspended in stock market & fraud conviction in U.S.

Posted by in categories: business, finance, law

This company’s entry in the US; market; along with other aluminum giants is said to have caused the shutdown of a large number of Aluminum manufacturers based in the US. It seemed that local US companies were unable to compete with state backed companies which were taking advantage of the free trade agreement.

However, the trade tariffs along with recent events have in turn caused this firm to become insolvent. It’s founder is now being detained by the US under fraud charges.

Continue reading “China: Corporate debt crisis spreads/Zhongwang: suspended in stock market & fraud conviction in U.S.” »

Nov 1, 2021

Will This Generation Of “Climate Tech” Be Different?

Posted by in categories: climatology, computing, finance

There’s no question about it: climate technology is in again.

Over the past several quarters, entrepreneurial activity and investment interest in climate tech have skyrocketed. New funds devoted specifically to climate have launched at an astonishing rate in 2021: from blue-chip venture capital firms like Union Square Ventures, from large private equity players like TPG and General Atlantic, from a whole new breed of climate-specific VCs like Lowercarbon Capital. Scarcely a day goes by now without a climate tech startup announcing a major new funding round. A whopping $49 billion of venture capital funding will pour into climate tech in 2021.

BlackRock CEO Larry Fink aptly captured the current ebullience when he declared last week that “the next 1,000 unicorns” will be in climate tech.

Page 3 of 9612345678Last